Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
ICUCW
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
seekingalpha.comPOSITIVO
Seastar medical targets NEUTRALIZE-AKI enrollment completion around year-end or Q1 2027 as QUELIMMUNE adoption reaches 20 hospitals
Earnings Call Insights: SeaStar Medical Holding Corporation (ICU) Q2 2026 MANAGEMENT VIEW * "We are very pleased with our progress this quarter" and "Our pediatric AKI market penetration and continued strong QUELIMMUNE revenue growth bodes…
There are notable gap-ups and gap-downs in today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps. [gap] GAP UP STOCKS TICKER CHANGE COMMENT GMHS [htt…
Stay updated with the stocks that are on the move in today's pre-market session.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMME…
Here are the top movers in Friday's session, showcasing the stocks with significant price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT EEIQ [https://www.chartmill.com/stock/quote/EEIQ/profile] 137.0% In an impressive move…
SeaStar Medical Announces Positive Nasdaq Listing Determination
SeaStar Medical DENVER, July 02, 2025 (GLOBE NEWSWIRE) -- Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential lo…
SeaStar Medical Reports Update on Nasdaq Listing Status
SeaStar Medical DENVER, June 25, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and poten…
SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children
SeaStar Medical Holding Corporation Data being presented at the American Society of Nephrology (ASN) Kidney Week 2022 Interim study data show that SCD treatment is safe to use in pediatric patientswith Acute Kidney Injury (AKI)requiring co…
SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts
SeaStar Medical Holding Corporation –Company advancing clinically proven platform therapy,the Selective Cytopheretic Device (SCD),to address the life-threatening consequences of hyperinflammation –SCD lead program in Acute Kidney Injury (A…